{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380865424828811144.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Mohit Tripathi"}],"foaf:familyName":[{"@value":"Tripathi"}],"foaf:givenName":[{"@value":"Mohit"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360865424828811136","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1038/s41467-023-39970-9"},{"@type":"URI","@value":"https://www.nature.com/articles/s41467-023-39970-9.pdf"},{"@type":"URI","@value":"https://www.nature.com/articles/s41467-023-39970-9"}],"notation":[{"@value":"An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/s41467-023-39970-9_5fXEP8W5VGOURbwIRn4JMPxOyqs"}]}